Turning scientific complexity into strategic clarity.
VEXAI Studio is a New York-based innovation advisory. We combine PhD-level scientific evaluation, AI strategy, and decision modeling to help leaders in life sciences, consumer health, and climate tech make high-confidence technology and investment decisions.
Scroll to explore
About Us
Our team brings PhD-level scientific depth and has operated within and alongside organizations including Fortune 500 R&D divisions, U.S. national laboratories, venture-backed startups, and academic research institutions.
Our team's accomplishments include:
Designed the enterprise AI strategy for a Fortune 500 global R&D organization, mapping workflows across clinical, product, and regulatory functions and building executive alignment for responsible AI adoption.
Built integrated techno-economic and scenario models for emerging energy technologies, used by teams to guide capital allocation and technology selection under uncertainty.
Led scientific evaluation and partnership structuring for a global open innovation program spanning peptides, delivery systems, and digital diagnostics.
Published research spans peptide therapeutics, targeted drug delivery, techno-economic analysis, and carbon strategy.
What we do
(01)
AI Readiness & R&D Strategy
We map your R&D workflows, identify where AI creates real value, and design adoption roadmaps your team will actually follow.
(02)
Techno-Economic & Scenario Modeling
We build integrated models that quantify trade-offs across cost, performance, emissions, and risk to support capital allocation and technology selection.
(03)
Science Translation & Claims Strategy
We turn complex R&D into credible investor narratives, defensible product claims, and clear market positioning.
(04)
Innovation Scouting & Partnership Strategy
We identify, evaluate, and structure technology partnerships across your innovation landscape — from startups and research labs to platform providers.
(05)
Sustainability & Carbon Strategy
We integrate sustainability into technology and investment decisions as a strategic input to capital allocation, not a compliance exercise.
(06)
Technology Due Diligence
We evaluate the science, model the economics, and assess the risk — so you can make investment, partnership, or portfolio decisions with confidence.